期刊文献+

围产期心肌病发病机制和诊治进展 被引量:7

Pathogenesis,Diagnosis and Treatment of Peripartum Cardiomyopathy
暂未订购
导出
摘要 围产期心肌病(PPCM)是指发生在孕妇分娩前或后,首发以心肌病变为基本特征及充血性心力衰竭为主要临床表现的心脏病变。PPCM病因和发病机制不明,可能与病毒感染、自身免疫反应、血流动力学异常、营养不良等因素有关。诊断需排除导致心力衰竭的其他常见病因,如缺血性心肌病、高血压性心脏病、瓣膜病等,超声心动图检查有确诊价值。PPCM早期诊断和规范化心力衰竭治疗,心脏功能可完全恢复正常。PPCM患者病死率为5%~32%,临床预后与左心室大小及心功能的恢复程度相关。 Peripartum cardiomyopathy (PPCM) occurred before or after pregnant women, and cardiomyopathy is the basic characteris- tics. Congestive heart failure is the main clinical manifestations. The cause and pathogenesis of PPCM is unknown, and it may be related to virus infection, autoimmune reactions, hemod3mamic abnormalities, malnutrition or etc. The diagnosis must rule out other common causes of heart failure,such as ischemie cardiomyopathy, hypertensive heart disease, valvular disease, etc. Echocardiography inspection have the val- ue. The early diagnosis of PPCM and standardized treatment of heart failure are very important. Cardiac function can be completely restored to normal. The fatality rate of PPCM is 5% - 32%, and the clinical outcomes are related to the left ventricular size and the recovery degree of cardiac function.
作者 艾民 颜昌福
出处 《心血管病学进展》 CAS 2013年第3期437-440,共4页 Advances in Cardiovascular Diseases
关键词 围产期心肌病 妊娠 心力衰竭 心脏扩大 peripamun cardiomyopathy pregnancy heart failure enlargement of the heart
  • 相关文献

参考文献4

二级参考文献128

  • 1王志民,邹玉宝,宋雷,马爱群,刘唐威,谷惠敏,卢赛兰,武鹏翥,孙兆明,何国宝,张卫,张颖,沈丽,蔡玉岭,甄一松,刘延玲,惠汝太.超声心动图检查调查8080例成人肥厚型心肌病患病率[J].中华心血管病杂志,2004,32(12):1090-1094. 被引量:63
  • 2张寄南,曹克将.肥厚型心肌病诊断与治疗——美国心脏病学学会/欧洲心脏病学学会、美国心脏病协会专家共识导读[J].中华心血管病杂志,2005,33(6):491-494. 被引量:35
  • 3廖玉华,袁璟.扩张型心肌病分子免疫治疗靶点的研究进展[J].中华医学杂志,2006,86(17):1158-1160. 被引量:8
  • 4王德智 张振钧.全国妇产科降低围产期母儿死亡率学术研讨会纪要[J].中国实用妇科与产科杂志,1994,10:53-54.
  • 5杜旭 王世程 等.围产期心肌病125例临床分析[J].中华妇产科杂志,1986,21(6):337-337.
  • 6Mone SM, Sanders SP, Clolan SD. Control mechanisms for physiologic hypertrophy of pregnancy. Circulation, 1996, 94: 667-672.
  • 7Mandal D, Mandal S, Mukherjee D, et al Pregnancy and sulxsequant pregnancy outcomes in peripartum cardiomyopathy. J Obstet Gynaecol Res, 2011, 37: 222- 227.
  • 8Palmer BA, Lanosko KM, McTieman C, et al. Left ventricular recovery in peripartum cardiomyopathy. Circulation, 2007, 116 (Suppl2): 551.
  • 9Biteker M, Duran NE, Kaya H, et al. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol, 2011, 100.. 571-577.
  • 10Sliva K, Tibazarwa K, Hiliker- Kleiner D. Management of peripartum cardiomyopathy. Curr Heart Fail Rep, 2008, 5: 238 - 244.

共引文献587

同被引文献49

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部